Contact
Xenon Genetics About Xenon  
About Xenon Investors News and Media Drug Discovery Program Science and Technology Careers  
 
 
Scientific Publications

  1. Lin, L. et al. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood, Volume 106, 2884-2889, October, 2005

  2. Papanikolaou, G. et al. Hepcidin in iron overload disorders. Blood, Volume 105, 4103-4105, May, 2005

  3. MacDonald, ML. et al. Genetic variants of frizzled-4 gene in familial exudative vitreoretinopathy and advanced retinopathy of prematurity, Clinical Genetics, Volume 67, 363-366, April, 2005

  4. Delatycki, MB. et al. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis, Clinical Genetics, Volume 65, 378-383, May, 2004

  5. Lafreniere, RG. et al. Identification of a novel gene (HSN2) causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates, American Journal of Human Genetics, Volume 74, 1064-1073, May, 2004

  6. Hovingh, GK. et al. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease, Journal of the American College of Cardiology, Volume 44, 1429-1435, October, 2004

  7. Papanikolaou, G. et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis, Nature Genetics, Volume 36, 77-82, January, 2004

  8. Hovingh, GK. et Al. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia, Journal of Lipid Research, Volume 44, 1251-1255, June, 2003

  9. Wellington, CL. et al. Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol, Journal of Lipid Research, Volume 43, 1939-1949, November, 2002

  10. Robitaille, J. et al. Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy, Nature Genetics, Volume 32, 326-330, October 1, 2002

  11. Attie, A. et al. Relationship between Stearoyl-CoA Desaturase Activity and Plasma Triglyceride in Human and Mouse Hypertriglyceridemia, Journal of Lipid Research, Volume 43, 1899-1907, August 16, 2002

  12. Ntambi, J. et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity, Proc. Natl. Acad. Sci., Volume 99, 11482-11486, August, 2002
  13. Singaraja, R. et al. Increased ABCA1 activity protects against atherosclerosis, Journal of Clinical Investigation, Volume 110, 35-42, July, 2002

  14. Cohen, P. et al. Role of Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss, Science, Volume 297, 240-243, July 12, 2002

  15. Bu, L. et al. Mutant DNA-binding domain of HSF4 is associated with autosomal dominant lamellar and Marner contact, Nature Genetics, Volume 31, 276-278, July 2002

  16. Cossette, P. et al, Mutation of GABRA1 in autosomal dominant form of juvenile myoclonic epilepsy, Nature Genetics, Volume 31, 184-189, June 2002

  17. Clee, S.M. et al, Common Genetics Variation in ABCA1 Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease, Circulation, Volume 103, 1198-1205, February 12, 2001

  18. Miyazaki, M. et al. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monosaturated fatty acids for triglyceride synthesis, Journal of Lipid Research, Volume 42, 1018-1024, 2001

  19. Nadler, S.T. et al. The expression of adipogenic genes is decreased in obesity and diabetes mellitus, PNAS, Volume 97, 11371-11376, October 10, 2000

  20. Miyazaki, M. et al. The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1*, The Journal of Biological Chemistry, Volume 275, 30132-30138, September 29, 2000

  21. Brooks-Wilson, A. et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency, Nature Genetics, Volume 22, 336-345, August 1999

  22. Scott, J. Good cholesterol news, Nature, Volume 400, 816-819, August 26, 1999
 
About Xenon Investors News and Media Drug Discovery Program Science and Technology Careers
Home Site Map Contact  

   Copyright © 2001 - 2008 Xenon All rights reserved. See legal terms for use of site.